Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
QTTB on Nasdaq
There are no Buy or Sell transactions made by David S. Grayzel since 10/6/2023
Holdings reported by David S. Grayzel for Q32 Bio Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
864K |
$494K |
$0.57 |
Mar 25, 2024 |
By Atlas Venture Fund X, L.P. |
|
|
| Common Stock |
725K |
$414K |
$0.57 |
Mar 25, 2024 |
By Atlas Venture Opportunity Fund II, L.P. |
|
|
| Common Stock |
503K |
$287K |
$0.57 |
Mar 25, 2024 |
By Atlas Venture Opportunity Fund I, L.P. |
|
|
| Stock Option (Right to Buy) |
2.57K |
$34.5K |
$13.42 |
Apr 1, 2024 |
Direct |
Common Stock |
|
Transactions reported by David S. Grayzel for Q32 Bio Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.